DK363887A - Anvendelse af bromcruptin - Google Patents

Anvendelse af bromcruptin

Info

Publication number
DK363887A
DK363887A DK363887A DK363887A DK363887A DK 363887 A DK363887 A DK 363887A DK 363887 A DK363887 A DK 363887A DK 363887 A DK363887 A DK 363887A DK 363887 A DK363887 A DK 363887A
Authority
DK
Denmark
Prior art keywords
bromcruptin
Prior art date
Application number
DK363887A
Other languages
Danish (da)
English (en)
Other versions
DK363887D0 (da
Inventor
Douglas Larson
Peter Hiestand
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of DK363887D0 publication Critical patent/DK363887D0/da
Publication of DK363887A publication Critical patent/DK363887A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK363887A 1986-07-14 1987-07-13 Anvendelse af bromcruptin DK363887A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US88511086A 1986-07-14 1986-07-14

Publications (2)

Publication Number Publication Date
DK363887D0 DK363887D0 (da) 1987-07-13
DK363887A true DK363887A (da) 1988-01-15

Family

ID=25386156

Family Applications (1)

Application Number Title Priority Date Filing Date
DK363887A DK363887A (da) 1986-07-14 1987-07-13 Anvendelse af bromcruptin

Country Status (13)

Country Link
JP (1) JPS6323817A (enrdf_load_stackoverflow)
KR (1) KR880001292A (enrdf_load_stackoverflow)
AU (1) AU602154B2 (enrdf_load_stackoverflow)
CH (1) CH672987A5 (enrdf_load_stackoverflow)
DE (1) DE3722383A1 (enrdf_load_stackoverflow)
DK (1) DK363887A (enrdf_load_stackoverflow)
FR (1) FR2601245A1 (enrdf_load_stackoverflow)
GB (1) GB2192541B (enrdf_load_stackoverflow)
IT (1) IT1224222B (enrdf_load_stackoverflow)
NL (1) NL8701631A (enrdf_load_stackoverflow)
PH (1) PH24525A (enrdf_load_stackoverflow)
SE (1) SE8702843L (enrdf_load_stackoverflow)
ZA (1) ZA875145B (enrdf_load_stackoverflow)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3814521A1 (de) * 1987-05-07 1988-11-17 Sandoz Ag Neue anwendung von dopaminrezeptor-agonisten
EP0327040A3 (de) * 1988-02-05 1990-11-28 Predrag Dr.Sc. Sikiric Verwendung von Dopamin und/oder von Dopamin-Agonisten zur Herstellung eines Arzneimittels für die Behandlung des Verdauungstrakts
US5716932A (en) * 1988-05-10 1998-02-10 Louisiana State University And Agricultural And Mechanical College Process for the long term reduction of body fat stores, insulin resistance, and hyperinsulinemia in vertebrates
US6004972A (en) * 1988-05-10 1999-12-21 The Board Of Supervisiors Of Louisiana State University And Agricultural And Mechanical College Therapeutic process for the treatment of the pathologies of type II diabetes
US5700800A (en) * 1988-05-10 1997-12-23 Ergo Science Incorporated Methods for the long term reduction of body fat stores, insulin resistance, hyperinsulinemia and hyperglycemia in vertebrates with a prolactin stimulatory compound
US5585347A (en) * 1988-05-10 1996-12-17 Ergo Science Incorporated Methods for the determination and adjustment of prolactin daily rhythms
US5744477A (en) * 1988-05-10 1998-04-28 The Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Method for treatment of obesity using prolactin modulators and diet
US5830895A (en) * 1988-05-10 1998-11-03 The Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Methods for the determination and adjustment of prolactin daily rhythms
US5468755A (en) * 1988-05-10 1995-11-21 The Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Therapeutic process for the treatment of the pathologies of Type II diabetes
US5668155A (en) * 1988-05-10 1997-09-16 The General Hospital Corporation Administration of pirenzepine, methyl scopolamine and other muscarinic receptor antagonists for treatment of lipid metabolism disorders
US5344832A (en) * 1990-01-10 1994-09-06 The Board Of Supervisors Of Louisiana University And Agricultural And Mechanical College Method for the long term reduction of body fat stores, insulin resistance, hyperinsulinemia and hyperglycemia in vertebrates
CA2030174C (en) * 1990-01-10 1996-12-24 Anthony H. Cincotta Process for the long term reduction of body fat stores, insulin resistance, hyperinsulinemia and hypoglycemia in vertebrates
WO1993012793A1 (en) * 1991-12-23 1993-07-08 The Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College A therapeutic process for the treatment of the pathologies of type ii diabetes
US5696128A (en) * 1994-07-07 1997-12-09 The Board Of Supervisors Of Louisiana University And Agricultural And Mechanical College Method of regulating immune function
IL112106A0 (en) * 1993-12-22 1995-03-15 Ergo Science Inc Accelerated release composition containing bromocriptine
US5714519A (en) * 1995-06-07 1998-02-03 Ergo Science Incorporated Method for regulating glucose metabolism
US5626860A (en) * 1995-06-07 1997-05-06 The Board Of Supervisors Of Louisana State And Agricultural And Mechanical College Method for regulating metabolism with dopamine beta hydroxylase inhibitors
US20010016582A1 (en) 1997-04-28 2001-08-23 Anthony H. Cincotta Method and composition for the treatment of lipid and glucose metabolism disorders
JP5407865B2 (ja) * 2006-11-23 2014-02-05 ジノクサ ファルマ ゲーエムベーハー 毛細管動脈疾患治療用医薬組成物
DK3445362T3 (da) * 2016-04-20 2021-10-11 Veroscience Llc Sammensætning og fremgangsmåde til behandling af stofskiftesygdomme
PL3697418T3 (pl) 2017-10-18 2025-02-03 Veroscience Llc Polepszone preparaty bromokryptyny
CA3149877A1 (en) 2019-09-23 2021-04-01 Anthony H. Cincotta Method for inducing tumor regression

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH507249A (de) * 1968-05-31 1971-05-15 Sandoz Ag Verfahren zur Herstellung von 2-Brom-a-ergokryptin
CH666406A5 (de) * 1984-02-29 1988-07-29 Sandoz Ag Verfahren zur herstellung von mikrokapseln, welche bromokriptinmesylat als pharmakologischen wirkstoff enthalten.
GB2154874B (en) * 1984-02-29 1987-11-04 Sandoz Ltd Bromoscriptine compositions

Also Published As

Publication number Publication date
GB2192541B (en) 1990-05-02
KR880001292A (ko) 1988-04-22
NL8701631A (nl) 1988-02-01
JPS6323817A (ja) 1988-02-01
DK363887D0 (da) 1987-07-13
GB2192541A (en) 1988-01-20
GB8716323D0 (en) 1987-08-19
FR2601245A1 (fr) 1988-01-15
CH672987A5 (enrdf_load_stackoverflow) 1990-01-31
DE3722383A1 (de) 1988-01-28
IT1224222B (it) 1990-09-26
AU602154B2 (en) 1990-10-04
SE8702843L (sv) 1988-01-15
SE8702843D0 (sv) 1987-07-13
ZA875145B (en) 1989-02-22
PH24525A (en) 1990-07-18
IT8748160A0 (it) 1987-07-10
AU7558787A (en) 1988-01-21

Similar Documents

Publication Publication Date Title
DK208188D0 (da) Anvendelse af 17-ketosteroider
DK363887D0 (da) Anvendelse af bromcruptin
DK193588A (da) Anvendelser af dopaminagonister
DK662687D0 (da) Anvendelse af tricycliske carbazoloner
DK185988D0 (da) Anvendelse af antigen
DK120389A (da) Anvendelse af progestin
DK564886D0 (da) Fungicid anvendelse af tetrahydrobenzothienylurinstofderivater
DK38593D0 (da) Alkoxymethylethere af glyceroler
DK102389D0 (da) Anvendelse af interleukin
DK87888A (da) Terapeutisk anvendelse af tindijoddeuteroporfyrin
FI882238L (fi) Foerbaettringar i samband med organiska foereningar
DK541487A (da) Sammenfoejning af materialer
DK293787D0 (da) Ekspression af en amyloglucosidase
DK237385A (da) Anvendelse af dihydroergotamin
DK289887D0 (da) Anvendelse af avaron- og avarolderivater
DK289987D0 (da) Anvendelse af avaron- og avarolderivater
DK309888D0 (da) Fremstilling af glyceraldehyd-3-phosphat-dehydrogenase
DK185987D0 (da) Anvendelse af prostaglandiner
DK333587A (da) Anvendelse af pyridinderivater
DK135387D0 (da) Fremstilling af proteiner
DK153045C (da) Sammenkobling af fortrinsvis langstrakte elementer
ES296589Y (es) Conjunto parcial de peluca
SE8603968D0 (sv) New use
DK0402857T3 (da) Anvendelse af 17beta-cyclopropylamino-androsten-derivater
DK171389D0 (da) Anvendelse af acetazolamid

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment